1. Home
  2. MRK
  3. MRK News

Latest Merck & Company Inc. (new) (MRK) News on September 18, 2025

Netflix upgraded, Five Below initiated: Wall Street's top analyst calls
MRK

The Fly

a day ago

Netflix upgraded, Five Below initiated: Wall Street's top analyst calls

Advancing Cancer Research Brings New Hope for Patients Worldwide
MRK

CNW Group

a day ago

Advancing Cancer Research Brings New Hope for Patients Worldwide

The Zacks Analyst Blog Highlights Alphabet, IBM, Merck, SandRidge Energy and NeurAxis
MRK

Zacks

a day ago

The Zacks Analyst Blog Highlights Alphabet, IBM, Merck, SandRidge Energy and NeurAxis

MRK

MT Newswires

a day ago

Rothschild & Co Redburn Adjusts Price Target on Merck & Co. to $120 From $115, Maintains Buy Rating

MRK

MT Newswires

a day ago

Berenberg Downgrades Merck & Co. to Hold From Buy, Adjusts Price Target to $90 From $100

Workday to acquire Swedish AI company Sana for $1.1bn
MRK

Verdict

a day ago

Workday to acquire Swedish AI company Sana for $1.1bn

MRK

Zacks

2 days ago

Top Research Reports for Alphabet, IBM & Merck

Where is Merck & Co. (MRK) Headed According to Analysts?
MRK

Insider Monkey

2 days ago

Where is Merck & Co. (MRK) Headed According to Analysts?

Merck (MRK) And Daiichi Sankyo's R-DXd Receives FDA Breakthrough Therapy Designation
MRK

Simply Wall St.

3 days ago

Merck (MRK) And Daiichi Sankyo's R-DXd Receives FDA Breakthrough Therapy Designation

Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PT
MRK

Insider Monkey

3 days ago

Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PT

Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab
MRK

Business Wire

3 days ago

Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab

How Bad Is This Sector’s Health Scare?
MRK

The Wall Street Journal

3 days ago

How Bad Is This Sector’s Health Scare?

MRK

MT Newswires

3 days ago

Update: Market Chatter: AstraZeneca Pauses $271 Million Cambridge Project

2 Healthcare Dividend Stocks to Buy and Hold
MRK

Motley Fool

4 days ago

2 Healthcare Dividend Stocks to Buy and Hold

Leerink Partners Remains Bullish on Merck & Co. (MRK)
MRK

Insider Monkey

5 days ago

Leerink Partners Remains Bullish on Merck & Co. (MRK)

Exclusive-AstraZeneca pauses $270 million investment in Britain
MRK

Reuters

6 days ago

Exclusive-AstraZeneca pauses $270 million investment in Britain

Merck & Co., Inc. (MRK) Reports Positive Topline Results from its Phase 3 CORALreef Lipids Trial
MRK

Insider Monkey

6 days ago

Merck & Co., Inc. (MRK) Reports Positive Topline Results from its Phase 3 CORALreef Lipids Trial

Health Care Roundup: Market Talk
MRK

The Wall Street Journal

6 days ago

Health Care Roundup: Market Talk

Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl
MRK

Barrons.com

6 days ago

Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl

Merck (MRK) Outpaces Stock Market Gains: What You Should Know
MRK

Zacks

7 days ago

Merck (MRK) Outpaces Stock Market Gains: What You Should Know

Merck (MRK) Announces Positive Phase 3 Results For 21-Valent Pneumococcal Vaccine
MRK

Simply Wall St.

7 days ago

Merck (MRK) Announces Positive Phase 3 Results For 21-Valent Pneumococcal Vaccine

MSD calls off £1bn UK expansion amid government-big pharma tensions
MRK

Pharmaceutical Technology

7 days ago

MSD calls off £1bn UK expansion amid government-big pharma tensions

Merck Falls 14% YTD: Time to Buy, Sell or Hold the Stock?
MRK

Zacks

7 days ago

Merck Falls 14% YTD: Time to Buy, Sell or Hold the Stock?

Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold?
MRK

Zacks

7 days ago

Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold?

MRK

MT Newswires

7 days ago

Merck Says Capvaxive Shows Immune Response in Children With High-Risk of Pneumococcal Disease in Phase 3 Trial

CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease
MRK

Business Wire

7 days ago

CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease

Britain defends investment record as Merck scraps labs over pharma environment
MRK

Reuters

7 days ago

Britain defends investment record as Merck scraps labs over pharma environment

Haduvio Opportunity Positions Trevi (TRVI) for Multibagger Gains, Says Morgan Stanley
MRK

Insider Monkey

7 days ago

Haduvio Opportunity Positions Trevi (TRVI) for Multibagger Gains, Says Morgan Stanley

3 Stocks Under $50 We Find Risky
MRK

StockStory

8 days ago

3 Stocks Under $50 We Find Risky

MRK

MT Newswires

8 days ago

Sector Update: Health Care Stocks Retreat Late Afternoon

US pharma giant Merck ditches plan for $1.4-bn research centre in UK
MRK

AFP

8 days ago

US pharma giant Merck ditches plan for $1.4-bn research centre in UK

MRK

MT Newswires

8 days ago

Sector Update: Health Care Stocks Lower in Afternoon Trading

MRK

MT Newswires

8 days ago

Trump Signs Memorandum to Crack Down on Misleading Direct-to-Consumer Drug Ads

Guggenheim Initiates Summit Therapeutics (SMMT) With a Buy Rating
MRK

Insider Monkey

9 days ago

Guggenheim Initiates Summit Therapeutics (SMMT) With a Buy Rating

SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study
MRK

Zacks

9 days ago

SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study

Will LLY's Oncology Portfolio Provide Key Diversification Benefits?
MRK

Zacks

9 days ago

Will LLY's Oncology Portfolio Provide Key Diversification Benefits?

Will Merck's Cost Cuts and New Drug Approvals Ease Headwinds?
MRK

Zacks

9 days ago

Will Merck's Cost Cuts and New Drug Approvals Ease Headwinds?

Merck (MRK) Gains Breakthrough Therapy Designation For Lung Cancer Drug
MRK

Simply Wall St.

10 days ago

Merck (MRK) Gains Breakthrough Therapy Designation For Lung Cancer Drug

Phanes Therapeutics announces first biliary tract carcinoma (BTC) patient dosed in clinical study of spevatamig in combination with chemotherapy
MRK

PR Newswire

10 days ago

Phanes Therapeutics announces first biliary tract carcinoma (BTC) patient dosed in clinical study of spevatamig in combination with chemotherapy

Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch
MRK

Investor's Business Daily

10 days ago

Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch

J&J vs. AbbVie: Which Healthcare Powerhouse Is Better Positioned?
MRK

Zacks

10 days ago

J&J vs. AbbVie: Which Healthcare Powerhouse Is Better Positioned?

Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences
MRK

Benzinga

10 days ago

Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences

Top Dividend Stocks To Consider In September 2025
MRK

Simply Wall St.

10 days ago

Top Dividend Stocks To Consider In September 2025

MRK

MT Newswires

10 days ago

Merck Says Phase 2 Study of Potential Lung Cancer Drug Showed 'Clinically Meaningful' Response Rates

Ifinatamab Deruxtecan Demonstrated Clinically Meaningful Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial
MRK

Business Wire

11 days ago

Ifinatamab Deruxtecan Demonstrated Clinically Meaningful Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial

Leerink Partners Maintained a Buy on Merck & Co (MRK)
MRK

Insider Monkey

11 days ago

Leerink Partners Maintained a Buy on Merck & Co (MRK)

Companies Kick Off September With Deluge of Bond Sales
MRK

The Wall Street Journal

11 days ago

Companies Kick Off September With Deluge of Bond Sales

How Positive Phase 3 Results for Enlicitide Could Shape Merck’s (MRK) Cardiovascular Ambitions
MRK

Simply Wall St.

12 days ago

How Positive Phase 3 Results for Enlicitide Could Shape Merck’s (MRK) Cardiovascular Ambitions

WHO adds weight loss drugs to essential medicines list
MRK

Quartz

13 days ago

WHO adds weight loss drugs to essential medicines list

Companies tap US bond market for nearly $70 billion, starting September on a busy note
MRK

Reuters

13 days ago

Companies tap US bond market for nearly $70 billion, starting September on a busy note

Merck (MRK) Impresses with New Cholesterol Drug in CORALreef Trial
MRK

Insider Monkey

13 days ago

Merck (MRK) Impresses with New Cholesterol Drug in CORALreef Trial

Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions
MRK

GlobeNewswire

13 days ago

Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions

NSCLC: three trials to keep an eye on
MRK

Clinical Trials Arena

14 days ago

NSCLC: three trials to keep an eye on

MRK

MT Newswires

14 days ago

Eli Lilly's Lung Cancer Drug Candidate Gets FDA Breakthrough Therapy Designation

3 Things You Need to Know if You Buy Pfizer Today
MRK

Motley Fool

14 days ago

3 Things You Need to Know if You Buy Pfizer Today

Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
MRK

Business Wire

15 days ago

Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions

US corporate debt market returns in force after market holiday
MRK

Reuters

15 days ago

US corporate debt market returns in force after market holiday

MRK Posts Cholesterol Drug Data, Focus Shifts Back to Its Pipeline
MRK

Zacks

15 days ago

MRK Posts Cholesterol Drug Data, Focus Shifts Back to Its Pipeline

J&J Gears Up for Some Key New Drug Approvals and Launches
MRK

Zacks

15 days ago

J&J Gears Up for Some Key New Drug Approvals and Launches

More Ways to Cut Cholesterol, Triglycerides Are Coming. This Stock Took Off.
MRK

Barrons.com

16 days ago

More Ways to Cut Cholesterol, Triglycerides Are Coming. This Stock Took Off.

This Merck Pill Promises Powerful Cholesterol Reduction Without Injections
MRK

Benzinga

16 days ago

This Merck Pill Promises Powerful Cholesterol Reduction Without Injections

Merck (MRK) Announces Positive Results From Phase 3 CORALreef Lipids Trial
MRK

Simply Wall St.

16 days ago

Merck (MRK) Announces Positive Results From Phase 3 CORALreef Lipids Trial

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
MRK

Motley Fool

16 days ago

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

MRK

Morningstar Research

16 days ago

Analyst Report: Merck & Co., Inc.

Will Opdivo and Opdivo Qvantig Drive BMY's Top-Line Growth?
MRK

Zacks

16 days ago

Will Opdivo and Opdivo Qvantig Drive BMY's Top-Line Growth?

MRK

MT Newswires

16 days ago

Market Chatter: Merck Selling Bonds to Help Fund Verona Acquisition

Can Korlym Drive Corcept's Growth Through the Rest of 2025?
MRK

Zacks

16 days ago

Can Korlym Drive Corcept's Growth Through the Rest of 2025?

MRK

MT Newswires

16 days ago

Merck Says Enlicitide Met Primary and Secondary Endpoints in Hypercholesterolemia Study

MRK

MT Newswires

16 days ago

Merck's Verquvo Fails to Meet Primary Endpoint in Phase 3 Victor Trial

Merck’s Investigational Oral PCSK9 Inhibitor Enlicitide Decanoate Met All Primary and Key Secondary Endpoints in Adults with Hypercholesterolemia in Pivotal CORALreef Lipids Study
MRK

Business Wire

16 days ago

Merck’s Investigational Oral PCSK9 Inhibitor Enlicitide Decanoate Met All Primary and Key Secondary Endpoints in Adults with Hypercholesterolemia in Pivotal CORALreef Lipids Study

Merck to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
MRK

Business Wire

16 days ago

Merck to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Merck & Co., Inc. (MRK) Launches $3B Plan to Reinvest Ahead of Keytruda Patent Expiry in 2028
MRK

Insider Monkey

16 days ago

Merck & Co., Inc. (MRK) Launches $3B Plan to Reinvest Ahead of Keytruda Patent Expiry in 2028

NVIDIA Corporation (NVDA): Take A Look At Jim Cramer’s 1,000+ Words About The Stock After Q2 Earnings
MRK

Insider Monkey

18 days ago

NVIDIA Corporation (NVDA): Take A Look At Jim Cramer’s 1,000+ Words About The Stock After Q2 Earnings

Merck & Co. (MRK) Announces First Patient Dosage in HERTHENA-Breast04 Phase 3 Trial
MRK

Insider Monkey

19 days ago

Merck & Co. (MRK) Announces First Patient Dosage in HERTHENA-Breast04 Phase 3 Trial

How Much Would It Take To Earn $100 A Month From Merck Stock
MRK

Benzinga

19 days ago

How Much Would It Take To Earn $100 A Month From Merck Stock

Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction
MRK

Business Wire

19 days ago

Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction

Is Merck Stock Outperforming the Dow?
MRK

Barchart

20 days ago

Is Merck Stock Outperforming the Dow?

ABBV or MRK: Which Stock Should Investors Place Their Bet on in 2025?
MRK

Zacks

20 days ago

ABBV or MRK: Which Stock Should Investors Place Their Bet on in 2025?

MRK

MT Newswires

20 days ago

DBS Bank Adjusts Merck Price Target to $100 From $96, Maintains Buy Rating

Here’s How Wall Street is Reacting to Verona Pharma (VRNA)’s Acquisition
MRK

Insider Monkey

21 days ago

Here’s How Wall Street is Reacting to Verona Pharma (VRNA)’s Acquisition

Veeva Systems (VEEV) Reports Strong Q2 Earnings With US$789 Million Revenue
MRK

Simply Wall St.

21 days ago

Veeva Systems (VEEV) Reports Strong Q2 Earnings With US$789 Million Revenue

Merck (MRK) Up 2.8% Since Last Earnings Report: Can It Continue?
MRK

Zacks

21 days ago

Merck (MRK) Up 2.8% Since Last Earnings Report: Can It Continue?

MRK, Daiichi Begin Phase III Breast Cancer Study With ADC Candidate
MRK

Zacks

21 days ago

MRK, Daiichi Begin Phase III Breast Cancer Study With ADC Candidate

Can Pfizer's Cost Cuts and New Drugs Offset Upcoming Headwinds?
MRK

Zacks

21 days ago

Can Pfizer's Cost Cuts and New Drugs Offset Upcoming Headwinds?

Will Weak Gardasil Sales Continue to Be a Drag on MRK's Top Line?
MRK

Zacks

21 days ago

Will Weak Gardasil Sales Continue to Be a Drag on MRK's Top Line?

Merck to Participate in the 2025 Wells Fargo Healthcare Conference
MRK

Business Wire

21 days ago

Merck to Participate in the 2025 Wells Fargo Healthcare Conference

Merck & Co., Inc. (MRK) Expands Targeted Therapy Pipeline with ADC Advances
MRK

Insider Monkey

21 days ago

Merck & Co., Inc. (MRK) Expands Targeted Therapy Pipeline with ADC Advances

Moderna, Inc. (MRNA) Expands Into Oncology with Pan-Tumor Vaccine
MRK

Insider Monkey

21 days ago

Moderna, Inc. (MRNA) Expands Into Oncology with Pan-Tumor Vaccine

MRK

ACCESS Newswire

22 days ago

Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

MRK

MT Newswires

22 days ago

Merck's Phase 3 Trial for Metastatic Breast Cancer Treatment Doses First Patient

HERTHENA-Breast04 Phase 3 Trial of Patritumab Deruxtecan Initiated in Patients with Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer Previously Treated with Endocrine Therapy
MRK

Business Wire

22 days ago

HERTHENA-Breast04 Phase 3 Trial of Patritumab Deruxtecan Initiated in Patients with Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer Previously Treated with Endocrine Therapy

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma
MRK

GlobeNewswire

22 days ago

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma

Rising as One, Shining as Many - Global New Material International opens a new chapter for Zhejiang entrepreneurs going global on 29 August 2025
MRK

GlobeNewswire

23 days ago

Rising as One, Shining as Many - Global New Material International opens a new chapter for Zhejiang entrepreneurs going global on 29 August 2025

MRK

Argus Research

23 days ago

The Argus High-Yield Model Portfolio

Can Label Expansion of Cabometyx Fuel Further Growth for EXEL?
MRK

Zacks

23 days ago

Can Label Expansion of Cabometyx Fuel Further Growth for EXEL?

IOVA Stock Drops 6% on $350M Common Stock Offering
MRK

Zacks

23 days ago

IOVA Stock Drops 6% on $350M Common Stock Offering

Dow Loses About 350 Points After Record-Breaking Run
MRK

The Wall Street Journal

24 days ago

Dow Loses About 350 Points After Record-Breaking Run

Stock Market Today: Dow Drops, Apple Firm Despite Musk Threat; Cathie Wood Loads Up On This Stock (Live Coverage)
MRK

Investor's Business Daily

24 days ago

Stock Market Today: Dow Drops, Apple Firm Despite Musk Threat; Cathie Wood Loads Up On This Stock (Live Coverage)

Merck (MRK) Unveils New Cardiovascular Research Data at ESC 2025 Congress
MRK

Simply Wall St.

24 days ago

Merck (MRK) Unveils New Cardiovascular Research Data at ESC 2025 Congress

Exelixis vs. Merck: Which Oncology Stock Is a Better Pick as of Now?
MRK

Zacks

24 days ago

Exelixis vs. Merck: Which Oncology Stock Is a Better Pick as of Now?

Share on Social Networks: